Tag: Prescription Drugs
Younger Kidney Cancer Patients on VEGF Inhibitors at Elevated Risk for Hypertension
Vascular endothelial growth factor inhibitors tied to hypertension among people aged 18 to 39 years being treated for renal cancer
Major Drug Shortages Not Likely After Tornado Damages Pfizer Plant, FDA Says
Pfizer is working to repair the damage and mitigate any shortage of drugs made at the facility
SGLT2i Use Linked to Reduced Risk for Flare in Adults With Gout, T2D
Flare rate lower among SGLT2i initiators than DDP-4i initiators; gout-primary emergency department visits, hospitalizations also reduced
Ketamine Efficacious for Treatment-Resistant Depression
Four-week course efficacious and safe for treatment-resistant depression
Fruquintinib Provides Meaningful Benefit in Refractory Metastatic CRC
Significantly improved overall survival seen with fruiquintinib versus placebo, with favorable safety profile
JAK Inhibitors May Aid Hair Regrowth in Patients With Alopecia
Study shows safety and tolerability of JAK inhibitors acceptable
Solanezumab Does Not Slow Cognitive Decline in Preclinical Alzheimer Disease
Mean change in Preclinical Alzheimer Cognitive Composite score not significantly different at 240 weeks with solanezumab, placebo
One-Hour Training Improves Documentation to Diagnose, Treat Tardive Dyskinesia
Implementation of training session increased proportion of patients with documented Abnormal Involuntary Movement Score
Donanemab Slows Clinical Progression in Early Alzheimer Disease
Slows clinical progression at 76 weeks for those with low/medium tau and the combined low/medium and high tau pathology population
Determinants of Overall Survival in Metastatic Uveal Melanoma Identified
Female sex, anti-CTLA‐4 therapy, and anti-PD‐1 therapy linked to better overall survival, while worse survival seen with hepatic metastases
